M&G invests in medical diagnostic firm Osler

Written by Michael Griffiths

07/11/2022

M&G has announced an investment in medical diagnostic company, Osler Diagnostics.

The investment, an $85m Series C financing round, has been made by M&G’s Catalyst strategy, which invests in innovative, privately-owned global businesses working to create a more sustainable world.

Osler, which provides lab-quality diagnostic testing, was formed out of the University of Oxford in 2017. This investment marks Catalyst’s latest investment in UK academic innovation and impact, following previous investments that include Vaccitech and Oxford Nanopore Technologies.

M&G stated that the funding will support the company in advancing its Osler Origin product through regulatory activities, and towards a market launch. The Osler Origin is a portable diagnostic capable of performing a wide range of testing in a rapid, low-cost manner. According to Osler, it has the potential to offer a wide portfolio of diagnostic tests into all major healthcare settings, globally.

Global head of investments at Catalyst, Niranjan Sirdeshpande, commented: “The Osler Origin has the potential to transform the speed and accuracy of diagnostics so patients receive much-needed medical interventions in a timely manner.

“Through our investment in Osler and wider investments Catalyst has made into academic spin outs, we are seeking to back innovative companies that will contribute towards creating a more sustainable world.”

Co-founder and chief executive of Osler, Connor Campbell, added: “The Osler Origin platform has the potential to transform healthcare by enabling anyone, anywhere, to access, understand, and act on their healthcare information. This new investment allows us to advance the Osler Origin towards market, and to realise our vision.”

Related Articles